Merck Animal Health

Merck Canada

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. 

This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

NGM Biopharmaceuticals

Just - Evotec Biologics

eASIC

SAB Biotherapeutics

Alnylam Pharmaceuticals

Hangzhou Just Biotherapeutics (Just China)

Sutro Biopharma

Themis Bioscience

Seagen

Private Capital Advisors

Gavi, the Vaccine Alliance

Merck

A diverse workforce is not only fundamental to our company's future success, but it's also a part of our rich history. 
 
🧬 Susan Jenkins paved the way for black women in science at Merck, as part of the team that first synthesized ribonuclease. She also served as a black university liaison in our company's corporate equal employment affairs department.
 
⚾️ After the integration of Major league Baseball, star pitcher, Jimmy Dean, famous for his sinker-ball found a second career at Merck until retiring from his position as a technical analyst in 1990.
 
👥 In 1968, Merck appointed Lawrence “Larry” Branch vice president of personnel relations, responsible for employment, training and promotion of persons from all minority groups. This new position marked the beginnings of Merck’s Office of Equal Employment Affairs — one of the first in the country to prioritize equity for black employees.
 
We remain committed to attracting and developing diverse talent during #BlackHistoryMonth and every day. Check out open roles to join our team: http://merck.us/49Qmxqe

Wife, mother, and employee, Gina Esposito, MSM-HC, had 20 years of normal cervical screenings before she was diagnosed with HPV-related #cervical precancer. Today she feels empowered to share her story with colleagues and encourage others to take care of their health.

This #BlackHistoryMonth, we want to raise awareness of the importance of diversity in clinical trials and our ongoing efforts to increase participation from communities that have historically been underrepresented in research. Hear from Ashley C. Moultrie, director of diversity & community engagement, on why it should be prioritized and the positive impact it can have on our efforts to help achieve health equity.

Heart failure impacts more than 6 million Americans. Robin and Ray, active members with The Mended Hearts, Inc., are living with the condition. Watch to learn about their experiences.

We’re proud to be one of Fortune's World’s Most Admired Companies for 2024, ranking No. 3 in the pharmaceuticals industry for the second year in a row! We’re grateful for the ongoing dedication of our colleagues, whose support has enabled us to achieve this recognition. 

Interested in joining one of the #MostAdmiredCos? See open roles at our company: https://lnkd.in/eSABXQ3

Through mentorship, education, and representation, let's empower women to explore science and technology. In honor of this #IDWGS, we spoke to three scientists at our company about how mentorship is helping fuel the next generation of #WomenInScience.

We’re proud to be named No. 1 in the pharmaceuticals and biotech industry for the fourth year in a row and No. 25 overall on CNBC and JUST Capital’s list of America’s Most JUST Companies. See open roles at our company to join us in helping to create a safer, healthier and more sustainable world for people and communities everywhere: https://lnkd.in/eSABXQ3 #MostJUST

Today we announce the upcoming retirement of EVP and Chief Human Resources Officer Steve Mizell. Betty Larson, a leader with more than 20 years in health care and human resources, will become our EVP and CHRO effective April 8.

We’re following the science this #WorldCancerDay as we work to discover innovations that can help more people no matter what stage of cancer they have, or so they may never be diagnosed at all.

Rob Davis, chairman and CEO, on our Q4 and full-year 2023 #earnings: http://merck.us/3HJtT2M

MSD Manual Professional

MSD Manual Consumer

Manual MSD versión pro

Manual MSD público general

Le Manuel MSD Professionnel

Manual MSD para Profissionais

MSD Vet Manual

默沙东诊疗手册（医学专业人士版）

Le Manuel MSD grand public

默沙东诊疗手册（大众版）

Domain Not Resolving

Google Font API

DNSSEC

Google Maps

Amazon

IPv6

Google

Google Cloud

U.S. Server Location

Facebook Sharer

Leslie Brun

Carlos Represas

Shelly Lazarus

Wendell Weeks

Pamela Craig

Inge Thulin

Paul Rothman

Peter Wendell

Phillip Samayoa

Associate Director, MRL Ventures

Hilary Wandall

SVP, Privacy Intelligence and General Counsel

Celeste Warren

Vice President Global Diversity and Inclusion COE

Bonnie Landy

Specialist, Learning & Development

Steven C. Mizell

EVP, Chief Human Resources Officer

Thomas Glocer

Director

Brian Thornley

Associate Vice President, Supply Excellence

Omair Aasim

Senior Java Developer

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

Zapata Computing is a quantum software company that offers computing solutions for industrial and commercial use.

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Themis Bioscience is a start-up biotechnology company.

Seagen is a clinical-stage biotechnology company dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.

eASIC is a fabless semiconductor company that offers NEW ASIC devices used to produce customized silicon devices.

Greater New York Area Companies (Top 10K)

East Coast Biotechnology Companies

Pharmaceutical Companies (Top 10K)

Investors Active in United States (Top 10K)

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases. The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives.

Post-IPO Equity - Merck

Venture Round - Merck

MSDAVENIR

Rahway

New Jersey

United States

North America

Merck to Participate in the Citi 2024 Global Healthcare Conference

Merck halts Phase 3 trial with PAH drug Winrevair following positive interim data

Regulatory actions for Nov. 25, 2024

Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Merck’s WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors

Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer

Surendralal Karsanbhai Elected to Merck Board of Directors

Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll

Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints

China

Asia

Singapore

India

Israel

HTML5

Comodo PositiveSSL Certificates

Google Tag Manager

Adobe Flash

Bootstrap

Google Analytics

Fonts.com

Wordpress

Google Fonts

GlobalSign

Merck owns Sirna Therapeutics

Merck owns Rosetta Inpharmatics

Merck owns NovaCardia

Merck owns MSD Serbia

Merck owns MRL Ventures Fund

Merck owns Merck Research Laboratories

Merck owns Merck Global Health Innovation Fund

Merck owns Merck Digital Sciences Studio

Merck owns Idenix Pharmaceuticals

Merck owns GlycoFi Inc.

Viavi Solutions is a global provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, and their ecosystems.

Viavi Solutions

Johnson & Johnson is a multinational corporation that develops medical devices, pharmaceutical, and consumer packaged goods.

Johnson & Johnson

Pfizer is a leading global pharmaceutical company that develops and produces medicines and vaccines for a wide range of medical disciplines.

Pfizer

Gilead Sciences is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines in areas of unmet medical need.

Gilead Sciences

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions.

AbbVie

Amgen is a multinational biopharmaceutical company that focuses on the discovery, development, and delivery of innovative human therapeutics.

Amgen

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines.

AstraZeneca

Novartis is a multinational pharmaceutical company that focuses on the research, development, manufacturing, and marketing of healthcare products.

Novartis

GlaxoSmithKline is a global healthcare company that researches and develops a broad range of innovative products in pharmaceuticals, vaccines, and consumer healthcare.

GlaxoSmithKline

Merck is a premier research-intensive biopharmaceutical company that develops important medicines and vaccines to save and improve lives worldwide. With a diverse and inclusive global workforce, the company operates responsibly to enable a safe, sustainable, and healthy future for all people and communities.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

news impact assignment basic	general	Mar 7, 2024 3:03 PM	3605d4dc
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	5f403bbd
news processing daily refresh	general	May 21, 2024 3:03 AM	f1f0ed8d
news impact assignment daily	general	May 21, 2024 3:35 PM	b9043975
news processing basic	general	Mar 7, 2024 3:03 PM	4b7283b7
company summary	general
signals	general	Mar 7, 2024 3:03 PM	c4ca601f
crunchbase trigger	general	Nov 27, 2024 12:50 PM	4f5abe23
crunchbase profile	general	Nov 27, 2024 1:03 PM	6a30629d
li profile	general	Mar 7, 2024 3:03 PM	ff8f20f8
translate crunchbase fundingrounds	general	Nov 27, 2024 3:00 PM	d00ba6bd
peers	general	Mar 7, 2024 3:03 PM	37236fd1
news basic	general	Dec 4, 2024 2:13 PM	5d07a0e3
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:MERCK

Merck & Co., Inc. (MSD outside of the U.S. and Canada)

Last Close

99.86

22/11 21:00

Market Cap

322.43B

Beta: -

Volume Today

14.03M

Avg: -